$REPL Replimune Group, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Replimune Group, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Replimune Group, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Replimune Group, Inc. for free.
IRS Number: 822082553
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: REPL
Company Address: 500 UNICORN PARK WOBURN 01801
Replimune Group, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11 2021 | REPL | Replimune Group, I ... | Lewis Tanya | Chief Dev. Oper. Of ... | Option Exercise | A | 33.99 | 110,000 | 3,738,900 | 110,000 | |
| May 11 2021 | REPL | Replimune Group, I ... | Lewis Tanya | Chief Dev. Oper. Of ... | Grant | A | 0.00 | 73,333 | 0 | 73,333 | 0 to 73.3 K |
| May 05 2021 | REPL | Replimune Group, I ... | Patel Sushil | Chief Commercial Of ... | Option Exercise | A | 36.75 | 125,000 | 4,593,750 | 125,000 | |
| May 05 2021 | REPL | Replimune Group, I ... | Patel Sushil | Chief Commercial Of ... | Grant | A | 0.00 | 88,333 | 0 | 88,333 | 0 to 88.3 K |
| Apr 19 2021 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Sell | S | 29.98 | 2,700 | 80,946 | 895,809 | 898.5 K to 895.8 K (-0.30 %) |
| Apr 19 2021 | REPL | Replimune Group, I ... | Love Colin | Chief Operating Off ... | Sell | S | 30.69 | 27,300 | 837,837 | 898,509 | 925.8 K to 898.5 K (-2.95 %) |
| Apr 05 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | A | 31.58 | 51,250 | 1,618,475 | 51,250 | |
| Apr 05 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Grant | A | 0.00 | 34,165 | 0 | 210,159 | 176 K to 210.2 K (+19.41 %) |
| Apr 05 2021 | REPL | Replimune Group, I ... | Pirzkall Andrea | Chief Medical Offic ... | Option Exercise | A | 31.58 | 30,750 | 971,085 | 30,750 | |
| Apr 05 2021 | REPL | Replimune Group, I ... | Pirzkall Andrea | Chief Medical Offic ... | Grant | A | 0.00 | 20,500 | 0 | 21,500 | 1,000 to 21.5 K (+2,050.00 %) |
| Apr 05 2021 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Option Exercise | A | 31.58 | 69,050 | 2,180,599 | 69,050 | |
| Apr 05 2021 | REPL | Replimune Group, I ... | Franchi Jean M. | Chief Financial Off ... | Grant | A | 0.00 | 46,035 | 0 | 46,035 | 0 to 46 K |
| Apr 05 2021 | REPL | Replimune Group, I ... | Coffin Robert | President & Chief R ... | Option Exercise | A | 31.58 | 115,300 | 3,641,174 | 115,300 | |
| Apr 05 2021 | REPL | Replimune Group, I ... | Coffin Robert | President & Chief R ... | Grant | A | 0.00 | 76,865 | 0 | 1,820,983 | 1.7 M to 1.8 M (+4.41 %) |
| Apr 05 2021 | REPL | Replimune Group, I ... | Astley-Sparke Philip | Chief Executive Off ... | Option Exercise | A | 31.58 | 128,125 | 4,046,188 | 128,125 |